What drove the after-hours move in HBMN.SW stock on 23 Jan 2026?

The after-hours rise to **CHF 244.00** followed an earnings release showing **EPS 13.66**. Traders reacted to stronger earnings, stable dividend metrics and a P/E of **17.68**, while volume remained light at **4,092** shares.

What are Meyka AI's short and long forecasts for HBMN.SW stock?

Meyka AI's model projects **CHF 237.52** as a monthly figure and **CHF 115.34** for the year. These imply short-term downside **-2.66%** and longer-term downside **-52.73%** versus **CHF 244.00**. Forecasts are projections, not guarantees.

How does HBMN.SW stock compare to sector peers on valuation?

HBM trades at **P/E 17.65**, close to the Financial Services sector average **P/E 16.71**, and at **price-to-book 0.96**, slightly below book value. That positions HBM as relatively value-oriented within its sector.

Does HBMN.SW stock pay a dividend and what is the yield?

Yes. HBM pays **dividend per share CHF 7.50**, giving a yield near **3.11%** and a payout ratio around **0.36**, supporting income-focused allocations while NAV drivers remain key.

CH Stocks

HBM Healthcare HBMN.SW (SIX) EPS 13.66 after-hours 23 Jan 2026: valuation focus

ByDanny Kontos January 23, 2026

HBMN.SW stock jumped after HBM Healthcare Investments AG reported strong earnings on 23 Jan 2026, lifting the share to CHF 244.00 in after-hours trading. The company posted EPS 13.66, a key driver of the +2.95% move from the previous close of CHF 237.00. We examine how the results affect valuation, dividend yield and investor outlook on the SIX Swiss exchange, and place the report in sector context using Meyka AI’s data-driven analysis.